InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (25 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
25
T+90 hit rate
29%
T+90 mean return
-6.7%
Across 17 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Sandercock Brett, Chief Financial Officer. Director active across 1 company, notably RESMED INC. Cumulatively, 51 disclosures have been recorded. Split: 0 buy · 25 sells. Total volume traded: €13.7m. History available since 10 May 2021. The latest transaction was filed on 8 April 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations51 total
1,000 shares@ US$215.580.7% of flowResMed Common StockSEC:0001127602-25-011925:0
1,000 shares@ US$230.360.8% of flowResMed Common StockSEC:0001127602-25-009188:0
1,000 shares@ US$238.980.9% of flowResMed Common StockSEC:0001127602-25-004042:0
1,000 shares@ US$234.040.9% of flowResMed Common StockSEC:0001127602-25-001067:0
1,000 shares@ US$244.230.9% of flowResMed Common StockSEC:0001127602-24-029095:0
1,000 shares@ US$249.000.9% of flowResMed Common StockSEC:0001127602-24-027030:0
1,000 shares@ US$233.470.8% of flowResMed Common StockSEC:0001127602-24-025369:0
1,000 shares@ US$246.420.8% of flowResMed Common StockSEC:0001127602-24-023758:0
7,915 shares0ResMed Common StockSEC:0001127602-24-022304:0
1,000 shares@ US$212.160.7% of flowResMed Common StockSEC:0001127602-24-021984:0
1,000 shares@ US$194.350.7% of flowResMed Common StockSEC:0001127602-24-020248:0
1,000 shares@ US$209.810.7% of flowResMed Common StockSEC:0001127602-24-018379:0
12,000 shares@ US$101.644.3% of flowResMed Common StockSEC:0001127602-24-014978:0
3,000 shares@ US$152.62011.6% of flowResMed Common StockSEC:0001127602-23-028436:0
4,972 shares0ResMed Common StockSEC:0001127602-23-022927:0
12,574 shares@ US$233.131510.1% of flowResMed Common StockSEC:0001127602-23-015482:0
3,426 shares@ US$232.0492.7% of flowResMed Common StockSEC:0001127602-23-015146:0
10,000 shares@ US$215.21967.6% of flowResMed Common StockSEC:0001127602-23-006460:0
4,000 shares@ US$215.003.0% of flowResMed Common StockSEC:0001127602-23-005095:0
14,577 shares0ResMed Common StockSEC:0001127602-22-026356:0
4,000 shares@ US$212.01693.2% of flowResMed Common StockSEC:0001127602-22-025209:0
3,847 shares0ResMed Common StockSEC:0001127602-22-021423:0
2,500 shares@ US$57.760.5% of flowResMed Common StockSEC:0001127602-22-020860:0
2,500 shares@ US$57.760.5% of flowResMed Common StockSEC:0001127602-22-019773:0
2,500 shares@ US$57.760.0004% mcap0.9% of flowResMed Common StockSEC:0001127602-22-011914:0
25 of 51 declarations
About Sandercock Brett
Brett Sandercock is an executive at RESMED INC.
